What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Antibiotics
- Bacteria
Microbiology, Antibiotics, Antibacterial agent, Antibiotic resistance and Internal medicine are his primary areas of study.
His research integrates issues of Bifidobacterium, Lactobacillus, Virology, Mycoplasma pneumoniae and Klebsiella in his study of Microbiology.
His study in Antibiotics is interdisciplinary in nature, drawing from both Ambulatory care, Drug resistance and Environmental health.
His Antibacterial agent study integrates concerns from other disciplines, such as Ciprofloxacin, Medical prescription and Levofloxacin.
His studies in Antibiotic resistance integrate themes in fields like Biotechnology, Acinetobacter baumannii, Antimicrobial and Infection control.
His Internal medicine research integrates issues from Placebo, Surgery and Intensive care medicine.
His most cited work include:
- Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. (3018 citations)
- Outpatient antibiotic use in Europe and association with resistance: a cross-national database study (2239 citations)
- Outpatient antibiotic use in Europe and association with resistance: a cross-national database study (2239 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of study are Microbiology, Antibiotics, Internal medicine, Antibiotic resistance and Intensive care medicine.
His study looks at the intersection of Microbiology and topics like Virology with NASBA.
The concepts of his Antibiotics study are interwoven with issues in Medical prescription, Antimicrobial, Pediatrics and Environmental health.
He combines subjects such as Epidemiology and Ambulatory care with his study of Pediatrics.
His research combines Drug resistance and Antibiotic resistance.
His Intensive care medicine research incorporates elements of Respiratory tract infections and Pneumonia.
He most often published in these fields:
- Microbiology (26.99%)
- Antibiotics (24.18%)
- Internal medicine (19.97%)
What were the highlights of his more recent work (between 2018-2021)?
- Internal medicine (19.97%)
- Antibiotics (24.18%)
- Antibiotic resistance (17.63%)
In recent papers he was focusing on the following fields of study:
His scientific interests lie mostly in Internal medicine, Antibiotics, Antibiotic resistance, Microbiology and Antimicrobial.
His research investigates the link between Internal medicine and topics such as Gastroenterology that cross with problems in Tobramycin.
His studies deal with areas such as Cohort and MEDLINE as well as Antibiotics.
His work deals with themes such as Ciprofloxacin, Metronidazole, Cefuroxime, Intensive care medicine and Drug resistance, which intersect with Antibiotic resistance.
His biological study spans a wide range of topics, including Pseudomonas aeruginosa, Acinetobacter baumannii and Plasmid.
His Antimicrobial research also works with subjects such as
- Point prevalence survey which connect with Environmental health, Antibiotic use and Antibiotic prescribing,
- Medical prescription that connect with fields like Psychological intervention and Family medicine,
- Antimicrobial stewardship that connect with fields like Emergency medicine,
- Surgical prophylaxis that intertwine with fields like Intensive care.
Between 2018 and 2021, his most popular works were:
- Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. (3018 citations)
- European Position Paper on Rhinosinusitis and Nasal Polyps 2020 (1843 citations)
- Seasonal coronavirus protective immunity is short-lasting. (207 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Bacteria
- Antibiotics
Herman Goossens mainly focuses on Antibiotic resistance, Internal medicine, Pandemic, Intensive care medicine and Antimicrobial.
His Antibiotic resistance research includes elements of Plasmid, Streptococcus pneumoniae, Molecular marker, Environmental health and Medical prescription.
His research on Pandemic also deals with topics like
- Coronavirus which is related to area like Severe acute respiratory syndrome coronavirus 2, Antibody and Virology,
- 2019-20 coronavirus outbreak and related Protective immunity, Healthy individuals and Acquired immune system.
Within one scientific family, he focuses on topics pertaining to Evidence-based medicine under Intensive care medicine, and may sometimes address concerns connected to Randomization, Community-acquired pneumonia, Sinusitis, Nasal polyps and Evidence-based practice.
Herman Goossens interconnects Antibiotics, Antibiotic use, Point prevalence survey, Meropenem and Drug resistance in the investigation of issues within Antimicrobial.
His study in Antibiotics focuses on Surgical prophylaxis in particular.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
